Skip to main content

Table 2 The rate of adverse effects by the groups

From: Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial

Adverse effect Daily treatment group Twice weekly group Significance
n % n %
Drowsiness 10 52.6 4 26.7 X2 = 0.12, df = 1, P = 0.1
Increased appetite 6 31.6 2 10.3 X2 = 0.2, df = 1, P = 0.2
Fatigue 2 10.5 % 2 10.3
Irritability 2 10.5 % 0
Headache 2 10.5 % 2 10.3
Nausea 1 5.3 2 10.3
Slowness 1 5.3 0
Abdominal pain 1 5.3 1 6.7
Dizziness 0 1 6.7
Drooling 1 5.3 0
Decreased appetite 0 0
Tremor 0 0
Itches 0 0
Convulsion 0 0
Akathisia 0 0
Dyskinesia 0 0
Diurnal urinary incontinency 0 0
Walking problem 0 0
Diarrhea 0 0
Vomiting 0 0
Insomnia 0 0
Swallowing difficulty 0 0
Blurred vision 0 0